Moleculin Biotech Inc (MBRX)
4.60
+0.30
(+6.98%)
USD |
NASDAQ |
Apr 23, 16:00
Moleculin Biotech Price: 4.60 for April 23, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 23, 2024 | 4.29 | 4.60 | 4.29 | 4.60 | 7381.00 |
Apr 22, 2024 | 4.78 | 4.78 | 4.30 | 4.30 | 16771.00 |
Apr 19, 2024 | 4.59 | 4.66 | 4.400 | 4.65 | 10562.00 |
Apr 18, 2024 | 4.49 | 5.00 | 4.41 | 4.524 | 49640.00 |
Apr 17, 2024 | 4.32 | 4.420 | 4.28 | 4.28 | 10408.00 |
Apr 16, 2024 | 4.55 | 4.740 | 4.28 | 4.28 | 15943.00 |
Apr 15, 2024 | 4.60 | 4.66 | 4.32 | 4.46 | 20009.00 |
Apr 12, 2024 | 4.82 | 4.97 | 4.54 | 4.627 | 18602.00 |
Apr 11, 2024 | 5.06 | 5.130 | 4.65 | 4.77 | 27798.00 |
Apr 10, 2024 | 5.69 | 5.91 | 4.81 | 5.20 | 31145.00 |
Apr 09, 2024 | 5.09 | 5.290 | 5.02 | 5.23 | 22165.00 |
Apr 08, 2024 | 5.12 | 5.340 | 5.00 | 5.05 | 53147.00 |
Apr 05, 2024 | 4.96 | 5.50 | 4.96 | 5.20 | 39769.00 |
Apr 04, 2024 | 5.29 | 5.31 | 5.05 | 5.30 | 15757.00 |
Apr 03, 2024 | 5.33 | 5.630 | 5.09 | 5.25 | 46587.00 |
Apr 02, 2024 | 5.70 | 5.70 | 5.18 | 5.45 | 28686.00 |
Apr 01, 2024 | 5.79 | 6.09 | 5.67 | 5.67 | 27055.00 |
Mar 28, 2024 | 5.58 | 6.235 | 5.179 | 5.91 | 78010.00 |
Mar 27, 2024 | 4.80 | 5.688 | 4.75 | 5.54 | 89261.00 |
Mar 26, 2024 | 4.95 | 4.99 | 4.34 | 4.68 | 92008.00 |
Mar 25, 2024 | 6.00 | 6.00 | 4.65 | 5.25 | 915721.0 |
Mar 22, 2024 | 5.56 | 6.24 | 5.30 | 5.705 | 98642.00 |
Mar 21, 2024 | 6.105 | 7.348 | 6.105 | 6.630 | 44753.00 |
Mar 20, 2024 | 7.800 | 7.800 | 6.000 | 6.309 | 65052.00 |
Mar 19, 2024 | 8.100 | 8.850 | 7.857 | 7.857 | 6012.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.28
Minimum
Apr 16 2024
156.60
Maximum
Apr 24 2019
47.60
Average
40.35
Median
Oct 06 2021
Price Benchmarks
Merck & Co Inc | 126.53 |
Lixte Biotechnology Holdings Inc | 3.57 |
Moderna Inc | 109.90 |
NovaBay Pharmaceuticals Inc | 0.0748 |
Palatin Technologies Inc | 1.76 |
Price Related Metrics
Price to Book Value | 0.393 |
Earnings Yield | -332.5% |
Market Cap | 10.25M |